Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
118,278,757
-
Share change
-
+3,924,984
-
Total reported value
-
$4,928,811,291
-
Put/Call ratio
-
110%
-
Price per share
-
$41.67
-
Number of holders
-
294
-
Value change
-
+$160,676,986
-
Number of buys
-
135
-
Number of sells
-
137
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q2 2018
As of 30 Jun 2018 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 294 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 118,278,757 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, Clearbridge Investments, LLC, BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, BB BIOTECH AG, BlackRock Inc., WADDELL & REED FINANCIAL INC, STATE STREET CORP, and OppenheimerFunds, Inc..
This table shows 294 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.